MAPT and tauopathy: Modulation of nuclear speckle content via loss of regulatory RNA-binding proteins resident in nuclear speckles, such as SUT-1 or SUT-2/MSUT2, can fully rescue tauopathy phenotypes in model systems including tau transgenic C. elegans, human cells and mouse brains [16, 19, 25].